When the deal wraps, Lonza will continue to make Genentech and Merck & Co. drugs there, such as the arthritis and Covid-19 ...

C OVID-19 medicine can help people who are at risk of, diagnosed with, or have symptoms of coronavirus disease 2019 (COVID-19). The medicine helps manage symptoms, stop the virus that causes COVID-19 ...

A recent IQVIA report found that uptake of biosimilars on the market for at least three years varies from 8% for insulin ...

and Actemra (tocilizumab) Targeted synthetic DMARDs that you take orally, such as Xeljanz (tofacitinib) Trexall (methotrexate) is the most common treatment when you first receive your diagnosis.

Previously, John was the VP & Franchise Head responsible for the commercial activities within Genentech’s Ophthalmology (Lucentis) and Rheumatology (Rituxan, Actemra) franchises for 10 ...

For patients with the auto-inflammatory disease VEXAS, treatment decisions are unfortunately fraught with tradeoffs between ...

Other treatments being tested on RECOVERY include Roche’s Actemra (tocilizumab), convalescent plasma from donors who have recovered from COVID-19 containing antibodies against the virus ...

The US government’s unveiling of the BIOSECURE bill has created a great deal of discussion and debate in the pharma industry.

A total of 23.8% of patients who experienced CRS required treatment with tocilizumab (Actemra). The median time to CRS onset ...

A total of 23.8% of patients who experienced CRS required treatment with tocilizumab (Actemra). The median time to CRS onset was 4 days (range, 1-7) after administration of the first dose of ...